Brian C Shonesy1, Walker P Parrish2, Hala K Haddad2, Jason R Stephenson2, Rita Báldi3, Rebecca J Bluett3, Christian R Marks2, Samuel W Centanni2, Oakleigh M Folkes3, Keeley Spiess2, Shana M Augustin4, Ken Mackie5, David M Lovinger4, Danny G Winder2, Sachin Patel6, Roger J Colbran2. 1. Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee. Electronic address: brian.shonesy@vanderbilt.edu. 2. Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee. 3. Department of Psychiatry, Vanderbilt University Medical Center, Nashville, Tennessee. 4. Laboratory for Integrative Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland. 5. The Gill Center and the Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana. 6. Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee; Department of Psychiatry, Vanderbilt University Medical Center, Nashville, Tennessee.
Abstract
BACKGROUND: Endocannabinoid signaling plays an important role in regulating synaptic transmission in the striatum, a brain region implicated as a central node of dysfunction in autism spectrum disorder. Deficits in signaling mediated by the endocannabinoid 2-arachidonoylglycerol (2-AG) have been reported in mouse models of autism spectrum disorder, but a causal role for striatal 2-AG deficiency in phenotypes relevant to autism spectrum disorder has not been explored. METHODS: Using conditional knockout mice, we examined the electrophysiological, biochemical, and behavioral effects of 2-AG deficiency by deleting its primary synthetic enzyme, diacylglycerol lipase α (DGLα), from dopamine D1 receptor-expressing or adenosine A2a receptor-expressing medium spiny neurons (MSNs) to determine the role of 2-AG signaling in striatal direct or indirect pathways, respectively. We then used viral-mediated deletion of DGLα to study the effects of 2-AG deficiency in the ventral and dorsal striatum. RESULTS: Targeted deletion of DGLα from direct-pathway MSNs caused deficits in social interaction, excessive grooming, and decreased exploration of a novel environment. In contrast, deletion from indirect-pathway MSNs had no effect on any measure of behavior examined. Loss of 2-AG in direct-pathway MSNs also led to increased glutamatergic drive, which is consistent with a loss of retrograde feedback inhibition. Subregional DGLα deletion from the dorsal striatum produced deficits in social interaction, whereas deletion from the ventral striatum resulted in repetitive grooming. CONCLUSIONS: These data suggest a role for 2-AG deficiency in social deficits and repetitive behavior, and they demonstrate a key role for 2-AG in regulating striatal direct-pathway MSNs.
BACKGROUND:Endocannabinoid signaling plays an important role in regulating synaptic transmission in the striatum, a brain region implicated as a central node of dysfunction in autism spectrum disorder. Deficits in signaling mediated by the endocannabinoid2-arachidonoylglycerol (2-AG) have been reported in mouse models of autism spectrum disorder, but a causal role for striatal 2-AG deficiency in phenotypes relevant to autism spectrum disorder has not been explored. METHODS: Using conditional knockout mice, we examined the electrophysiological, biochemical, and behavioral effects of 2-AG deficiency by deleting its primary synthetic enzyme, diacylglycerollipase α (DGLα), from dopamine D1 receptor-expressing or adenosine A2a receptor-expressing medium spiny neurons (MSNs) to determine the role of 2-AG signaling in striatal direct or indirect pathways, respectively. We then used viral-mediated deletion of DGLα to study the effects of 2-AG deficiency in the ventral and dorsal striatum. RESULTS: Targeted deletion of DGLα from direct-pathway MSNs caused deficits in social interaction, excessive grooming, and decreased exploration of a novel environment. In contrast, deletion from indirect-pathway MSNs had no effect on any measure of behavior examined. Loss of 2-AG in direct-pathway MSNs also led to increased glutamatergic drive, which is consistent with a loss of retrograde feedback inhibition. Subregional DGLα deletion from the dorsal striatum produced deficits in social interaction, whereas deletion from the ventral striatum resulted in repetitive grooming. CONCLUSIONS: These data suggest a role for 2-AG deficiency in social deficits and repetitive behavior, and they demonstrate a key role for 2-AG in regulating striatal direct-pathway MSNs.
Authors: Kristen K Ade; Yehong Wan; Harold C Hamann; Justin K O'Hare; Weirui Guo; Anna Quian; Sunil Kumar; Srishti Bhagat; Ramona M Rodriguiz; William C Wetsel; P Jeffrey Conn; Kafui Dzirasa; Kimberly M Huber; Nicole Calakos Journal: Biol Psychiatry Date: 2016-05-13 Impact factor: 13.382
Authors: Eduardo A V Marinho; Alexandre J Oliveira-Lima; Renan Santos; André W Hollais; Marilia A Baldaia; Raphael Wuo-Silva; Thais S Yokoyama; André L Takatsu-Coleman; Camilla L Patti; Beatriz M Longo; Laís F Berro; Roberto Frussa-Filho Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2014-12-10 Impact factor: 5.067
Authors: Olga Peñagarikano; Brett S Abrahams; Edward I Herman; Kellen D Winden; Amos Gdalyahu; Hongmei Dong; Lisa I Sonnenblick; Robin Gruver; Joel Almajano; Anatol Bragin; Peyman Golshani; Joshua T Trachtenberg; Elior Peles; Daniel H Geschwind Journal: Cell Date: 2011-09-30 Impact factor: 41.582
Authors: Brian C Shonesy; Rebecca J Bluett; Teniel S Ramikie; Rita Báldi; Daniel J Hermanson; Philip J Kingsley; Lawrence J Marnett; Danny G Winder; Roger J Colbran; Sachin Patel Journal: Cell Rep Date: 2014-11-26 Impact factor: 9.423
Authors: Jonathan Z Long; Weiwei Li; Lamont Booker; James J Burston; Steven G Kinsey; Joel E Schlosburg; Franciso J Pavón; Antonia M Serrano; Dana E Selley; Loren H Parsons; Aron H Lichtman; Benjamin F Cravatt Journal: Nat Chem Biol Date: 2008-11-23 Impact factor: 15.040
Authors: Daniel J Liput; Henry L Puhl; Ao Dong; Kaikai He; Yulong Li; David M Lovinger Journal: Neuropharmacology Date: 2021-12-09 Impact factor: 5.250
Authors: Don Wei; Sherab Tsheringla; James C McPartland; A Z A Stephen Azariah Allsop Journal: Philos Trans R Soc Lond B Biol Sci Date: 2022-07-11 Impact factor: 6.671
Authors: Brandon D Turner; Nicholas K Smith; Kevin M Manz; Betty T Chang; Eric Delpire; Carrie A Grueter; Brad A Grueter Journal: Psychopharmacology (Berl) Date: 2021-01-16 Impact factor: 4.530